The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a ...

The existing prediction models for severe complications of preeclampsia are most accurate only in the two days after hospital admission, with deteriorating performance over time, according to a new ...

Scientists have identified the most influential weather factors and combinations associated with an increase in Salmonella ...

Kansas City Chiefs will face the Philadelphia Eagles. Fans are discussing the Super Bowl logo controversy. The article highlights memorable Super Bowl logos, including those of Super Bowl XXVII ...

To Romania, the ancient helmet is a priceless cultural heirloom. To the Netherlands, it’s a stolen artifact that authorities hope to retrieve to uphold a reputation for safe museums. The ...

logo will not comply with upcoming new requirements ... Please try again. With a Kennebec Journal and Morning Sentinel subscription, you can gift 5 articles each month. It looks like you do ...

AMSTERDAM, Jan 22 (Reuters) - A Dutch court ordered the government on Wednesday to drastically cut nitrogen emissions in the Netherlands by 2030, a ruling that could hurt construction and will ...

Johnson Controls has acquired Webeasy, a Netherlands firm that supplies building management software and hardware. Webeasy's products allow access to building management systems via web browser ...

Abelacimab is a fully human monoclonal antibody that binds to the inactive form of factor XI and blocks its activation. The safety of abelacimab as compared with a direct oral anticoagulant in ...

The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative ...